Cargando…

Correction: YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients

Detalles Bibliográficos
Autores principales:	Xia, Yan, Chang, Ting, Wang, Yingmei, Liu, Yixiong, Li, Wenhui, Li, Ming, Fan, Heng-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807839/ https://www.ncbi.nlm.nih.gov/pubmed/27015277 http://dx.doi.org/10.1371/journal.pone.0152712

Ejemplares similares

YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
por: Xia, Yan, et al.
Publicado: (2014)

Correction: The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells
por: Cai, Hui, et al.
Publicado: (2013)

Correction: High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis
por: Hou, Minzhi, et al.
Publicado: (2020)

Correction: YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma
por: Yang, Chao, et al.
Publicado: (2022)

YAP/TEAD Co-Activator Regulated Pluripotency and Chemoresistance in Ovarian Cancer Initiated Cells
por: Xia, Yan, et al.
Publicado: (2014)

PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis
por: Wang, Yin, et al.
Publicado: (2016)

Correction: Abnormalities in Osteoclastogenesis and Decreased Tumorigenesis in Mice Deficient for Ovarian Cancer G Protein-Coupled Receptor 1
por: Li, Hui, et al.
Publicado: (2015)

Overexpression of PRC1 indicates a poor prognosis in ovarian cancer
por: Bu, Hualei, et al.
Publicado: (2020)

Correction: Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer
por: Zhan, Yonghao, et al.
Publicado: (2023)

Overexpression of RASAL1 Indicates Poor Prognosis and Promotes Invasion of Ovarian Cancer
por: Chang, Rui-Xia, et al.
Publicado: (2019)

Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer
por: Huang, Bihui, et al.
Publicado: (2016)

Capn4 overexpression indicates poor prognosis of ovarian cancer patients
por: Yang, Ming-Fang, et al.
Publicado: (2018)

A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer
por: Cheng, Zhongping, et al.
Publicado: (2015)

Overexpression of Growth-Related Oncogene-β Is Associated with Tumorigenesis, Metastasis, and Poor Prognosis in Ovarian Cancer
por: Ye, Qing, et al.
Publicado: (2015)

Correction to: Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway
por: Wang, Xuehui, et al.
Publicado: (2021)

Correction: The Chemoprevention of Ovarian Cancer: the Need and the Options
por: Kathawala, Rishil J., et al.
Publicado: (2018)

Correction: Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
por: Zhan, Yonghao, et al.
Publicado: (2023)

Correction: Identification of Ovarian Cancer Metastatic miRNAs
por: Vang, Souriya, et al.
Publicado: (2014)

Overexpression of miRNA-221 promotes cell proliferation by targeting the apoptotic protease activating factor-1 and indicates a poor prognosis in ovarian cancer
por: Li, Jie, et al.
Publicado: (2017)

Correction: ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells
por: Jeong, H. M., et al.
Publicado: (2019)

Correction to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients
por: Sun, Chaoyang, et al.
Publicado: (2020)

Correction to: Plexin-B1 silencing inhibits ovarian cancer cell migration and invasion
por: Ye, Shuangmei, et al.
Publicado: (2019)

Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer
por: Pei, Mei Li, et al.
Publicado: (2020)

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
por: Kim, H, et al.
Publicado: (2001)

Correction: Th1(high) in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC
por: Jian, Huang, et al.
Publicado: (2017)

Correction: Tumour-reactive T cell subsets in the microenvironment of ovarian cancer
por: Westergaard, Marie Christine Wulff, et al.
Publicado: (2019)

Correction to: Outcome quality standards in advanced ovarian cancer surgery
por: Llueca, Antoni, et al.
Publicado: (2020)

Baicalin Attenuates YAP Activity to Suppress Ovarian Cancer Stemness
por: Li, Yucong, et al.
Publicado: (2020)

Correction: SERPINB3 in the Chicken Model of Ovarian Cancer: A Prognostic Factor for Platinum Resistance and Survival in Patients with Epithelial Ovarian Cancer
por: Lim, Whasun, et al.
Publicado: (2013)

KCNH3 Predicts Poor Prognosis and Promotes Progression in Ovarian Cancer
por: Li, Zhongjun, et al.
Publicado: (2020)

Correction to: Arsenic nano complex induced degradation of YAP sensitized ESCC cancer cells to radiation and chemotherapy
por: Zhou, Wei, et al.
Publicado: (2021)

Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk
por: Dareng, Eileen O., et al.
Publicado: (2022)

Correction: Tamoxifen and Ovarian Function
por: Berliere, Martine, et al.
Publicado: (2013)

Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer
por: Peng, Chen, et al.
Publicado: (2020)

DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis
por: Xia, Leilei, et al.
Publicado: (2021)

Lymphocyte and macrophage infiltration in omental metastases indicates poor prognosis in advance stage epithelial ovarian cancer
por: Zhang, Tao, et al.
Publicado: (2021)

SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer
por: Váncza, Lóránd, et al.
Publicado: (2023)

Correction: Epimorphin-Induced MET Sensitizes Ovarian Cancer Cells to Platinum
por: Yew, Kok-Hooi, et al.
Publicado: (2013)

Correction: Blood type, ABO genetic variants, and ovarian cancer survival
Publicado: (2017)

Correction: An updated meta-analysis of the prognostic value of decreased E-cadherin expression in ovarian cancer
por: Yu, LiLi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rbv632bu3e9grribi01dts16rm